Bioceres Crop Solutions Corp. (BIOX) stock
Close on Nov 11, 2026Market cap $14.85MP/E –Yield –
Bioceres Crop Solutions Corp. saw revenue fall 17.7% to $238.28M over fiscal 2026. Operating income fell 454.8% to -$23.41M, moving the operating margin from 2.3% to -9.8%. Free cash flow was $64.96M, up 45.2% from a year earlier. At the latest close the market valued the company at $14.85M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Jun 30, 2026
Valuation
- Market cap
- $14.85M
- P/E ratio
- –
- Price to sales
- 0.06
- Price to book
- 1.39
- Dividend yield
- –
- Free cash flow yield
- 437.43%
Fundamentals
- Revenue
- $238.28M
- EPS, diluted
- -$4.06
- Free cash flow
- $64.96M
Trading
- Previous close
- $0.21
- Open
- $0.22
- Day's range
- $0.21 – $0.24
- Volume
- 93,533
- Average volume (20 days)
- 247,510
- Beta (5 years)
- 0.75
- 52-week range
- $0.19 – $2.03
- RSI (14 days)
- 43.3
- Volatility (1 year)
- 99.5%
- Relative volume
- 0.36×
- WACC
- 11.4%
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BIOX | S&P 500 | Difference | BIOX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -29.1% | -2.4% | −26.7 pts | ||
| 3 months | -35.1% | -1.2% | −34.0 pts | ||
| Year to date | -82.2% | +12.3% | −94.5 pts | ||
| 1 year | -87.9% | +12.4% | −100.4 pts | ||
| 3 years | -97.7% | +78.8% | −176.6 pts | -71.8% | +21.4% |
| 5 years | -98.3% | +75.2% | −173.5 pts | -55.9% | +11.9% |
Nine years at a glance
Fiscal years 2016 to 2026, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Bioceres Crop Solutions filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Bioceres Crop Solutions
Agricultural Chemicals
Bioceres Crop Solutions develops and markets agricultural productivity solutions aimed at enhancing crop performance and advancing sustainable farming practices. The company operates through three core segments: crop protection, seed and integrated products, and crop nutrition. Its product portfolio features adjuvants, pest control biopesticides, seed traits such as drought-tolerant HB4 technology, germplasm, and specialized seed treatment packs. It also provides biological crop nutrition solutions including bacterial inoculants, biofertilizers, and micro-beaded fertilizers. Bioceres serves a diverse customer base encompassing global agriculture corporations, commercial distributors, agricultural cooperatives, dealers, and individual farmers.
Company profile, executives and historyBioceres Crop Solutions stock: common questions
What is Bioceres Crop Solutions's stock price?
BIOX closed at $0.23 on Nov 11, 2026, up 8.48% on the day. Over the past 52 weeks it traded between $0.19 and $2.03.
What is Bioceres Crop Solutions's market cap?
Bioceres Crop Solutions was worth $14.85M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BIOX's P/E ratio?
Bioceres Crop Solutions lost money over fiscal 2026 (diluted EPS -$4.06), so it has no meaningful P/E ratio.
How much revenue does Bioceres Crop Solutions make?
Bioceres Crop Solutions reported revenue of $238.28M for fiscal 2026, down 17.7% from a year earlier.
Does Bioceres Crop Solutions pay a dividend?
No. Bioceres Crop Solutions has not paid a cash dividend over the last twelve months.
How has BIOX stock performed over the past year?
Including dividends, BIOX returned -87.9% over the past year, against +12.4% for the S&P 500.
How many BIOX shares are sold short?
0M shares were sold short at the latest FINRA report, 2.69% of the float, or 1.7 days of average trading volume.
Who are Bioceres Crop Solutions's competitors?
Companies most similar to Bioceres Crop Solutions by business, industry and size include AVD, UAN, SMG, CF, MOS.
See a number that looks wrong?